Publications by authors named "Eliane Madeleine Sophie Leyten"
Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection.
Janneke Evelyne Stalenhoef Cees van Nieuwkoop Darius Cameron Wilson Willize Elizabeth van der Starre Tanny J K van der Reijden Eliane Madeleine Sophie Leyten
BMC Infect Dis
February 2019
Background: A reduction in duration of antibiotic therapy is crucial in minimizing the development of antimicrobial resistance, drug-related side effects and health care costs. The minimal effective duration of antimicrobial therapy for febrile urinary tract infections (fUTI) remains a topic of uncertainty, especially in male patients, those of older age or with comorbidities. Biomarkers have the potential to objectively identify the optimal moment for cessation of therapy.
View Article and Find Full Text PDFArticle Synopsis
- Febrile urinary tract infections (fUTIs) can usually be treated with medicine at home, but some patients can get worse and develop serious complications.
- Doctors in the Netherlands studied a group of patients to see which tests could best predict if someone with fUTI would get very sick and need to be hospitalized.
- They found that a specific test called MR-proADM was the best at spotting serious cases, helping doctors know who might need more care and who could safely stay home.